Maitreya Medicare Ltd IPO

Maitreya Medicare Ltd IPO

Healthcare

sme

Bidding period

27 Oct 2023 - 01 Nov 2023

Bid price

₹82.00 - ₹82.00

Listing on

NSE-SME

Listing date

07 Nov 2023

Lot size

1600 shares

Issue size

₹14.89 crore


Minimum investment

₹1,31,200.00 / 2 lot

Maximum investment

₹1,31,200.00 / 1 lot

Bidding closed on 01 Nov 2023

Open Demat Account
Open Demat Account

Pre-issue Post-issue
Promoter group 99.88 73.11
Public group 0.12 26.89

Information currently unavailable

  • Key Multi-speciality tertiary and quaternary healthcare provider providing well diversified and specialized service offerings and strong brand recognition.

  • Regional leadership through delivering clinical excellance and affordable healthcare in South Gujrat.

  • Quality health care services.

  • Experienced senior management team.

  • Track Record of stable operating and financial performance and growth.

  • Ability to attract, train and retain high quality doctors, consultants and medical support staff.

  • The Hospital is highly dependent on its doctors, nurses and other healthcare professionals, as well as other key personnel and the loss of, or inability to attract or retain, such persons could adversely affect its business and results of operations.

  • There are outstanding legal proceedings involving the Hospital which may adversely affect its business, financial condition and results of operations.

  • The Hospital is highly dependent on its healthcare professionals including doctors, nurses that the hospital engage on a consultancy basis. If such medical staff discontinue their association with it or are unable to provide their services at the hospitals for any reason or if the hospital are unable to attract or retain such consultants/full time doctors, and other healthcare professionals, its business, results of operations and cash flows may be materially and adversely affected.

  • The Hospital has in the past not complied with some statutory provisions of the Companies Act, 2013/1956, further; there have been some instances of delay and non-filing of various forms which were required to be filed under the provisions of the Act, rules and regulations made thereunder with the RoC.

  • The Hospital may generate revenue from the arrangements with government sponsored health schemes, any adverse change in these regulations/ government policies related to such schemes may adversely affect its business, results of operations, cash flows and prospects.

  • The Hospital is yet to apply for approvals and licenses for the proposed Valsad hospital in the subsidiary Hospital Maitreya Hospital Pvt Ltd and can be applied only after operations are commenced, so in case the Hospital is unable to obtain required applicable approvals and licenses on time it will effect the Hospital revenues, credibility and future plans.

  • The Hospital is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could materially and adversely affect its reputation and prospects.

  • The Hospital operations are geographically located in one area at present and any localized social unrest, natural calamities, etc. could have material adverse effect on business and financial operations.

  • The Hospital is dependent on certain field of specialty for a substantial portion of its revenue, i.e. cardiology, neurology, Orthopedics and general medicine. Any material impact on the Hospital earnings from these fields will impact its financial condition and results of operations significantly.

  • Delay in receipt of payment from the Hospital patients/ customers may affect its cash flows, which may, in turn affect of the financial condition and results of operations.

MUFG Intime India Pvt Ltd

Phone number +91 810 811 4949
E-mail ID maitreyamedicare.ipo@linkintime.co.in
Website www.linkintime.co.in

QIB shares offered

3,29,600 (18.15%)

NII (HNI) shares offered

2,72,000 (14.98%)

Retail shares offered

6,11,200 (33.66%)

Anchor investor shares offered

4,94,400 (27.22%)

Total shares offered

18,16,000

Total shares with anchor investor

18,16,000

  • GYR Capital Advisors Pvt Ltd

Explore other IPOs

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)